Hepatitis B virus (HBV) is a primary etiology of hepatocellular carcinoma (HCC), accounting for over half of all cases globally.
Long non-coding RNAs (lncRNAs) have emerged as critical regulators of gene expression in hepatocellular carcinoma (HCC), interacting with mRNAs through complex networks to drive tumor initiation, progression, and therapy resistance.
This article comprehensively explores the critical roles of non-coding RNAs (ncRNAs)—including miRNAs, lncRNAs, and circRNAs—in reshaping the hepatocellular carcinoma (HCC) tumor microenvironment (TME).
This article comprehensively reviews the critical role of long non-coding RNAs (lncRNAs) in the pathogenesis of hepatocellular carcinoma (HCC), the most common form of primary liver cancer.
This review synthesizes current evidence on the transcription factor SOX9 as a novel immunomodulatory biomarker in cancer.
This article synthesizes current research on the transcription factor SOX9, exploring its complex and context-dependent roles in cancer biology.
This review synthesizes current research on the complex interplay between SOX9 and other SOX family transcription factors in regulating immune responses, particularly in cancer.
This comprehensive review explores the complex, context-dependent role of the transcription factor SOX9 in modulating immune responses within tumor microenvironments compared to normal tissues.
The transcription factor SOX9 is a pivotal, yet dualistic, regulator of the immune system, playing context-dependent roles in cancer immune escape, inflammatory diseases, and tissue repair.
This article synthesizes current research on the transcription factor SOX9 and its complex correlation with immune checkpoint markers across various cancers.